Skip to main content
THE PROOF LINE
Issue 03Field NotesWorkforce Watch

A Monitoring Visit Is Not a Checklist

Two CRAs can complete the same monitoring visit and leave behind very different levels of risk.

Rudy Malle, Founder, BORAKABy Rudy MalleFounder, BORAKA · · 6 min read

0% read on this device

Clinical monitoring materials with several small findings converging into a larger site risk pattern.
TRUVAN editorial illustration

A CRA can complete every item on a monitoring visit checklist and still miss the point of the visit.

That may sound harsh.

But anyone who has spent enough time around clinical operations knows exactly what I mean.

Monitoring is full of tasks that can be counted.

  • SDV completed.
  • Consent reviewed.
  • Regulatory documents checked.
  • IP accountability reviewed.
  • Queries generated.
  • Follow-up letter sent.
  • Visit report submitted.

All useful.

None of them, alone, tell me whether somebody monitored the site well.

The real work is judgement

The strongest monitors I have worked with do something that is much harder to capture in a checklist.

They recognize patterns.

They notice when three small issues are actually one large issue.

They understand that not every discrepancy carries the same risk.

They know when the coordinator needs coaching, when the investigator needs to become involved and when the sponsor needs an escalation.

They distinguish between "this field is incomplete" and "this site's process is breaking down."

That distinction is monitoring.

Same visit. Different CRA.

Imagine a site where several subjects have visit windows that are slightly outside protocol expectations.

CRA One documents each deviation.

The tracking system is updated.

The report is completed.

Technically, the work is done.

CRA Two notices something else.

The deviations cluster around a particular type of visit.

The coordinator is struggling to schedule those visits because the site's internal workflow creates a delay.

The CRA asks why.

They review the pattern.

They discuss corrective action with the site.

They assess whether other participants may be affected.

They determine whether the issue requires escalation.

Both CRAs found the deviations.

Only one found the system behind the deviations.

That is the difference between completing monitoring activities and exercising monitoring judgement.

This is why training gets difficult

You can teach somebody the components of a monitoring visit relatively quickly.

You can teach:

  • what belongs in the regulatory binder;
  • how informed consent should be reviewed;
  • what source documentation principles require;
  • how to identify a protocol deviation;
  • how IP accountability works;
  • how to write a monitoring report.

Those are foundations.

The harder part is learning how to think when several pieces of information collide.

That usually comes through experience.

But experience is not the only way to develop it.

  • Structured casework can help.
  • Simulation can help.
  • Reviewing real-world scenarios can help.
  • Having somebody explain why they made a decision can reveal far more than asking whether they know the definition of a deviation.

The question I would ask in a CRA interview

Instead of: "Tell me about your monitoring experience."

I would rather give the candidate a situation.

For example:

A site has repeated late data entry, two recent protocol deviations, an investigator who rarely attends monitoring visits and a coordinator who tells you they are overwhelmed. What do you do first?

Then I would keep asking why.

  • Why that issue first?
  • What evidence would you review?
  • What would make you escalate?
  • Who needs to be involved?
  • What would you document?
  • What would make you concerned that participant safety or data integrity is affected?

That conversation reveals the candidate's operating model.

And that is much closer to the work.

What should we actually be assessing?

For a monitor, I would want evidence across at least these dimensions.

  • Detection: can they identify what is wrong?
  • Prioritization: can they distinguish material risk from administrative noise?
  • Investigation: can they determine why the problem is happening?
  • Communication: can they address the issue without destroying the site relationship?
  • Escalation: do they know when the problem is no longer theirs to manage alone?
  • Documentation: can somebody reviewing the record later understand what happened and why?

That is a much richer picture than "five years CRA experience."

The proof line

A completed visit report proves that a monitoring visit occurred.

It does not automatically prove that strong monitoring occurred.

The difference is judgement.

And judgement leaves evidence if we know where to look for it.

That is one of the ideas I want The Proof Line to keep examining: what does good clinical research work actually look like when you get underneath the job title?

Share this issue

Discussion

What are you seeing? Add what this looks like where you work. Keep it professional, and do not post confidential study or employer information. Comments are moderated, so anything promotional is held before it appears.

Loading the discussion…

Sign in to join the discussion.

Subscribe

Get each issue of The Proof Line

Field intelligence on talent, competency, hiring and the work behind clinical trials. No promotional filler, and you can unsubscribe at any time.

What would you like to receive?